Raloxifene, a selective estrogen receptor modulator, is renoprotective: a post-hoc analysis
Author:
Publisher
Elsevier BV
Subject
Nephrology
Reference42 articles.
1. Chronic kidney disease: the global challenge;Meguid El Nahas;Lancet,2005
2. Prevalence of chronic kidney disease in the United States;Coresh;JAMA,2007
3. Excerpts from the United States Renal Data System 2004 annual data report: atlas of end-stage renal disease in the United States;Collins;Am J Kidney Dis,2005
4. Effect of gender on the progression of nondiabetic renal disease: a meta-analysis;Neugarten;J Am Soc Nephrol,2000
5. Risk factors for chronic kidney disease: a prospective study of 23,534 men and women in Washington County, Maryland;Haroun;J Am Soc Nephrol,2003
Cited by 48 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Combining raloxifene and mechanical loading improves bone composition and mechanical properties in a murine model of chronic kidney disease (CKD);Bone;2024-06
2. Differences in the epidemiology, management and outcomes of kidney disease in men and women;Nature Reviews Nephrology;2023-11-20
3. Ex vivo exposure to calcitonin or raloxifene improves mechanical properties of diseased bone through non-cell mediated mechanisms;Bone;2023-08
4. Final Stage of Chronic Kidney Disease with Conservative Kidney Management or Renal Replacement Therapy: A Primary-Care Population Study;Journal of Clinical Medicine;2023-07-11
5. The Selective Estrogen Receptor Modulator, Raloxifene, Is Protective Against Renal Ischemia–reperfusion Injury;Transplantation;2022-10-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3